File:Meta-analysis results for effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions (forest plot).png

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file(3,379 × 2,875 pixels, file size: 540 KB, MIME type: image/png)

Captions

Captions

DOR=Diagnostic odds ratios; From the study "The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research"

Summary[edit]

Description
English: "Forest plot of COVID-19 vaccine effectiveness among post-COVID conditions in individuals who received COVID-19 vaccine before or after COVID-19 infection. Diagnostic odds ratios (DOR) were determined with the DerSimonian and Laird random-effects method. Abbreviation: CI, confidence interval."

Note that at the x axis it says 1 and 1.25 – not 11.25.

"Thirty-two studies with 775,931 individuals evaluated the effect of vaccination on post-COVID conditions, of which, twenty-four studies were included in the meta-analysis. The pooled DOR for post-COVID conditions among fully vaccinated individuals was 0.680 (95% CI: 0.523–0.885) with an estimated VE of 32.0% (11.5%–47.7%). Vaccine effectiveness was 36.9% (23.1%–48.2%) among those who received two doses of COVID-19 vaccine before COVID-19 infection and 68.7% (64.7%–72.2%) among those who received three doses before COVID-19 infection. The stratified analysis demonstrated no protection against post-COVID conditions among those who received COVID-19 vaccination after COVID-19 infection."
Date
Source https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E#article
Author Authors of the study: Alexandre R. Marra, Takaaki Kobayashi, Gustavo Yano Callado, Isabele Pardo, Maria Celidonio Gutfreund, Mariana Kim Hsieh, Vivian Lin, Mohammed Alsuhaibani, Shinya Hasegawa, Joseph Tholany, Eli N. Perencevich, Jorge L. Salinas, Michael B. Edmond, and Luiz Vicente Rizzo

Licensing[edit]

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current16:34, 28 December 2023Thumbnail for version as of 16:34, 28 December 20233,379 × 2,875 (540 KB)Prototyperspective (talk | contribs)Uploaded a work by Authors of the study: Alexandre R. Marra, Takaaki Kobayashi, Gustavo Yano Callado, Isabele Pardo, Maria Celidonio Gutfreund, Mariana Kim Hsieh, Vivian Lin, Mohammed Alsuhaibani, Shinya Hasegawa, Joseph Tholany, Eli N. Perencevich, Jorge L. Salinas, Michael B. Edmond, and Luiz Vicente Rizzo from https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-sy...

There are no pages that use this file.

Metadata